Current Treatment Methods in Hepatocellular Carcinoma
Cancers · 04.12.2024 · 16 (23) · 4059
DOI: 10.3390/cancers16234059 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.12.2024. Verfasst von Kamila Krupa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Students' Scientific Organization of Cancer Cell Biology, Department of Oncological Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Polan…. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a prevalent malignant tumour worldwide. Depending on the stage of the tumour and liver function, a variety of treatment options are indicated. Traditional radiotherapy and chemotherapy are ineffective against HCC; however, the U.S. Food and Drug Administration (FDA) has approved radiofrequency ablation (RFA), surgical resection, and transarterial chemoembolization (TACE) for advanced HCC. On the other hand, liver transplantation is recommended in the early stages of the disease. Tyrosine kinase inhibitors (TKIs) like lenvatinib and sorafenib, immunotherapy and anti-angiogenesis therapy, including pembrolizumab, bevacizumab, tremelimumab, durvalumab, camrelizumab, and atezolizumab, are other treatment options for advanced HCC. Moreover, to maximize outcomes for patients with HCC, the combination of immune checkpoint inhibitors (ICIs) along with targeted therapies or local ablative therapy is being investigated. This review elaborates on the current status of HCC treatment, outlining the most recent clinical study results and novel approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Students' Scientific Organization of Cancer Cell Biology, Department of Oncological Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.
- Department of Oncological Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.
- Department of Oncology, National Medical Institute of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
- Department of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.
- Department of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.
ORCID-Profile: Anna Badowska-Kozakiewicz, Aleksandra Czerw, Andrzej Deptała
Zitieren
APA
Krupa, K., Fudalej, M., Cencelewicz-Lesikow, A., Badowska-Kozakiewicz, A., Czerw, A., & Deptała, A. (2024). Current Treatment Methods in Hepatocellular Carcinoma. Cancers, 16(23), 4059. https://doi.org/10.3390/cancers16234059
Vancouver
Krupa K, Fudalej M, Cencelewicz-Lesikow A, Badowska-Kozakiewicz A, Czerw A, Deptała A. Current Treatment Methods in Hepatocellular Carcinoma. Cancers. 2024;16(23):4059. doi:10.3390/cancers16234059
BibTeX
@article{Krupa2024,
author = {Krupa, Kamila and Fudalej, Marta and Cencelewicz-Lesikow, Anna and Badowska-Kozakiewicz, Anna and Czerw, Aleksandra and Deptała, Andrzej},
title = {Current Treatment Methods in Hepatocellular Carcinoma},
journal = {Cancers},
year = {2024},
volume = {16},
number = {23},
pages = {4059},
doi = {10.3390/cancers16234059}
}
EUVIMED